Susan Rodriguez
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Susan Rodriguez
Susan Rodriguez was last confirmed as Board Member at Heron Therapeutics, Inc. /De/ (HRTX) in a filing dated April 29, 2024. Heron Therapeutics, Inc. /De/ reported in an 8-K filed June 18, 2024 that Susan Rodriguez was appointed Director, effective June 13, 2024.
“to elect six director nominees: Craig Collard, Sharmila Dissanaike, M.D., FACS, FCCM, Craig Johnson, Susan Rodriguez, Christian Waage, and Adam Morgan, to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2021-01-01–2024-04-29
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.